Clinico-genetics in Korean Charcot-Marie-Tooth disease type 2Z withMORC2mutations
- 21 April 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 139 (7) , e40
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- X‐linked Charcot‐Marie‐Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 geneJournal of the Peripheral Nervous System, 2016
- MORC2 mutations cause axonal Charcot–Marie–Tooth disease with pyramidal signsAnnals of Neurology, 2015
- Mutations in theMORC2gene cause axonal Charcot–Marie–Tooth diseaseBrain, 2015
- CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysisJournal of Neurology, Neurosurgery & Psychiatry, 2014
- A cohort study of MFN2 mutations and phenotypic spectrums in Charcot–Marie–Tooth disease 2A patientsClinical Genetics, 2014
- Cytosolic functions of MORC2 in lipogenesis and adipogenesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- Charcot-Marie-Tooth diseaseNeurology, 2013
- Clinical implications of genetic advances in Charcot–Marie–Tooth diseaseNature Reviews Neurology, 2013
- MORC2 Signaling Integrates Phosphorylation-Dependent, ATPase-Coupled Chromatin Remodeling during the DNA Damage ResponseCell Reports, 2012
- The CpG dinucleotide and human genetic diseaseHuman Genetics, 1988